Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
ScholarIQanswers from OpenAlex

Survival with Osimertinib plus Chemotherapy in <i>EGFR</i> -Mutated Advanced NSCLC

PaperCitations, authors & open-access status

Survival with Osimertinib plus Chemotherapy in <i>EGFR</i> -Mutated Advanced NSCLC is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 80 citations, 2025 year and closed oa status.

80
Citations
2025
Year
closed
OA Status

Related on ScholarIQ

Bivas Biswas
Author
New England Journal of Medicine
Journal
Lung Cancer Treatments and Mutations
Topic
Lung Cancer Treatments and Mutations
Topic
Fibroblast Growth Factor Research
Topic
Lung Cancer Diagnosis and Treatment
Topic
470M+ articles · free account